The synthesis of New 5-R-aminoazolo[1,5-a]pyrimidin-7-ones from an N,S-acetal Derivative of Meldrum’s Acid

No abstract is available for this paper.

• Publication year

  2023

• Venue

  Chemistry of Heterocyclic Compounds

• Publication date

  2023-02-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1007/s10593-023-03164-4
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Evaluation of the Structure-Activity Relationship of Microtubule-Targeting 1,2,4-Triazolo[1,5-a]pyrimidines Identifies New Candidates for Neurodegenerative Tauopathies.

  2021cited by this paper
• Chemically Triggered Click and Declick Reactions: Application in Synthesis and Degradation of Thermosetting Plastics.

  2021cited by this paper
• Functional Pyrazolo[1,5-a]pyrimidines: Current Approaches in Synthetic Transformations and Uses As an Antitumor Scaffold

  2021cited by this paper
• 1,2,4-Triazolo[1,5-a]pyrimidines: Efficient one-step synthesis and functionalization as influenza polymerase PA-PB1 interaction disruptors.

  2021cited by this paper
• U.S. FDA Approved Drugs from 2015-June 2020: A Perspective.

  2021cited by this paper
• A Decade of FDA-Approved Drugs (2010-2019): Trends and Future Directions.

  2021cited by this paper
• Biological activities of [1,2,4]triazolo[1,5-a]pyrimidines and analogs

  2020cited by this paper
• 6-Nitro-4,7-dihydroazolo [1,5-a]pyrimidines: an alternative mechanism of formation and studies of alkylation

  2020cited by this paper
• Highly Stable Meldrum's Acid Derivatives for Irreversible Aqueous Covalent Modification of Amines.

  2020cited by this paper
• 1,2,4-Triazolo[1,5-a]pyrimidines in drug design.

  2019cited by this paper
• Biologically active azolo-1,2,4-triazines and azolopyrimidines

  2018cited by this paper
• Synthesis and Anticancer Evaluation of Some Novel 5‐Amino[1,2,4]Triazole Derivatives

  2018cited by this paper
• 6‐Nitroazolo[1,5‐a]pyrimidin‐7(4H)‐ones as Antidiabetic Agents

  2017cited by this paper
• Novel reversible methionine aminopeptidase-2 (MetAP-2) inhibitors based on purine and related bicyclic templates.

  2017cited by this paper
• The synthesis and evaluation of triazolopyrimidines as anti-tubercular agents

  2017cited by this paper
• Potent and Selective CK2 Kinase Inhibitors with Effects on Wnt Pathway Signaling in Vivo.

  2016cited by this paper
• A Broad Anti-influenza Hybrid Small Molecule That Potently Disrupts the Interaction of Polymerase Acidic Protein-Basic Protein 1 (PA-PB1) Subunits.

  2015cited by this paper
• Synthesis and evaluation of 1,2,4-triazolo[1,5-a]pyrimidines as antibacterial agents against Enterococcus faecium.

  2015cited by this paper
• Brain-Penetrant, Orally Bioavailable Microtubule-Stabilizing Small Molecules Are Potential Candidate Therapeutics for Alzheimer’s Disease and Related Tauopathies

  2014cited by this paper
• Structure and Property Based Design of Pyrazolo[1,5-a]pyrimidine Inhibitors of CK2 Kinase with Activity in Vivo.

  2013cited by this paper
• Potent and Selective Inhibitors of CK2 Kinase Identified through Structure-Guided Hybridization.

  2012cited by this paper
• Synthesis and structure-activity relationships of 1,2,4-triazolo[1,5-a]pyrimidin-7(3H)-ones as novel series of potent β isoform selective phosphatidylinositol 3-kinase inhibitors.

  2012cited by this paper
• A phase I dose escalation study of TTI-237 in patients with advanced malignant solid tumors

  2012cited by this paper
• Improvement of the synthesis and pharmacokinetic properties of chromenotriazolopyrimidine MDM2-p53 protein-protein inhibitors.

  2011cited by this paper
• Targeting PI3K signalling in cancer: opportunities, challenges and limitations

  2009cited by this paper
• Discovery and optimization of chromenotriazolopyrimidines as potent inhibitors of the mouse double minute 2-tumor protein 53 protein-protein interaction.

  2009cited by this paper
• The genetics of the p53 pathway, apoptosis and cancer therapy

  2008cited by this paper
• Synthesis and SAR of [1,2,4]triazolo[1,5-a]pyrimidines, a class of anticancer agents with a unique mechanism of tubulin inhibition.

  2007cited by this paper
• Characterization of the Interaction of Indiplon, a Novel Pyrazolopyrimidine Sedative-Hypnotic, with the GABAA Receptor

  2004cited by this paper
• Synthesis of .alpha.-cyano carbonyl compounds by flash vacuum thermolysis of (alkylamino)methylene derivatives of Meldrum's acid. Evidence for facile 1,3-shifts of alkylamino and alkylthio groups in imidoylketene intermediates

  1991cited by this paper

• A synthesis of novel 5-methylsulfanylazolo[1,5-a]pyrimidin-7(4H)-ones and investigation of their chemical and cytotoxic properties

  2024cites this paper